Memorializing Governor Kathy Hochul to proclaim June 9, 2026, as FSGS Awareness Day in the State of New York
This resolution memorializes the Governor to proclaim June 9, 2026, as FSGS Awareness Day in New York State. It describes focal segmental glomerulosclerosis (FSGS) as a rare, progressive kidney disease that can lead to kidney failure, dialysis, or transplantation, and emphasizes the importance of awareness, early diagnosis, and continued research. The resolution also highlights the role of patients, families, clinicians, researchers, and advocacy organizations in improving understanding and treatment of the disease.
The measure is primarily commemorative and educational rather than regulatory. It does not create new legal rights, duties, or funding obligations; instead, it urges executive recognition of the day and transmits the resolution to the Governor. The text frames FSGS as a significant public health issue because of its severity, its disproportionate impact on minority populations, and the strain it places on healthcare systems and families.
Because this is a Senate resolution, it does not amend the Public Health Law, Insurance Law, or any other statute, and it does not impose mandates on providers, insurers, or state agencies. Its practical effect is limited to formally recognizing FSGS Awareness Day and encouraging public education, early detection, and support for research and specialized care. The resolution may help elevate awareness among policymakers, healthcare professionals, and advocacy groups, but it has no direct legal or fiscal effect on state law.
The overall sentiment is strongly supportive and sympathetic toward patients and families affected by FSGS. The resolution presents the disease as serious, underrecognized, and deserving of public attention, and it praises ongoing research, clinical trials, and advocacy efforts. Because there is no recorded committee debate or vote history in the provided materials, there is no evidence of opposition in the available record.
No specific points of contention are identified in the provided text or legislative history. The resolution is noncontroversial in form, focusing on awareness and recognition rather than policy change. The only implicit policy emphasis is on the need for better access to nephrology care, earlier diagnosis, and continued investment in research, but no member or stakeholder objections are included in the record.